Buscar
Mostrando ítems 41-50 de 112
TAPcells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
(2013)
Here we summarize 10 years of effort in the development of a biomedical innovation with global projections. This innovation consists of a novel method for the production of therapeutic dendritic-like cells called Tumor ...
Pharmacoeconomic Evaluation Of Eligard® And Other Lhrh Analogues As Androgen Deprivation Therapy For Advanced And Metastatic Prostate Cancer [avaliação Farmacoeconômica De Diferentes Apresentações De Eligard® E Outros Análogos Lhrh Para Supressão Androgênica Em Pacientes Com Câncer De Próstata Avançado Ou Metastático]
(Moreira Junior Editora Ltda., 2014)
A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
(American Association for Cancer Research, 2013-01)
Galectins, a family of glycan-binding proteins, influence tumor progression by modulating interactions between tumor, endothelial, stromal, and immune cells. Despite considerable progress in identifying the roles of ...
Supervivencia e impacto en la calidad de vida, del uso del dietilestilbestrol en los pacientes con cáncer metastásico de próstata resistente a la castración
(Universidad Militar Nueva GranadaFacultad de MedicinaUrología OncológicaMedicina y Ciencias de la Salud - Urología Oncológica, 2019-06-20)
Problema: El pilar del tratamiento para los pacientes con cáncer metastásico de próstata es la terapia de supresión
androgénica. Una vez la enfermedad progresa y se considera resistente a la castración.
El dietilestilbestrol ...
Mucinous metaplasia in Pten conditional knockout mice and mucin family genes as prognostic markers for prostate cancer
(2022-03-15)
Aims: This study evaluated the association of mucinous metaplasia (MM) with tumor cell proliferation, androgen receptor (AR) expression and invasiveness in Pten conditional knockout mice and the prognostic value of MM ...
Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
(Frontiers Media, 2020-01-10)
Prostate cancer patients managed with androgen-deprivation therapy usually recur after a few years and the disease gradually becomes castration-resistant prostate cancer (CRPC). The role of tumor cell plasticity, including ...
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
(Wiley Blackwell Publishing, Inc, 2014-02)
5´AMP-activated kinase (AMPK) constitutes a hub for cellular metabolic and growth control, thus representing an ideal therapeutic target for prostate cancers (PCas) characterized by increased lipogenesis and activation of ...
Avaliação da atividade sinérgica entre compostos naturais puros e o quimoterápico docetaxel em modelos celulares de câncer de próstataEvaluation of synergic activity between pure natural substances and docetaxel chemotherapy in cellular models of prostate cancer
(Universidade Federal de UberlândiaBrasilPrograma de Pós-graduação em Genética e Bioquímica, 2021)